{"disease":{"id":"bcg","name":"bcg"},"drugs":{"marketed":[{"drug_id":"pembrolizumab","indication_name":"Urothelial Cancer (BCG-unresponsive)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Keytruda","generic_name":"pembrolizumab","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"PD-1 receptor","drug_class":"Monoclonal antibody; PD-1 inhibitor","quality_score":98,"revenue":"29500","mechanism":"Pembrolizumab blocks PD-1 receptor, releasing immune inhibition and enhancing anti-tumor T-cell response."},{"drug_id":"pembrolizumab","indication_name":"Urothelial Cancer (BCG-unresponsive)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Keytruda","generic_name":"pembrolizumab","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"PD-1 receptor","drug_class":"Monoclonal antibody; PD-1 inhibitor","quality_score":98,"revenue":"29500","mechanism":"Pembrolizumab blocks PD-1 receptor, releasing immune inhibition and enhancing anti-tumor T-cell response."},{"drug_id":"inbakicept","indication_name":"BCG-unresponsive NMIBC with CIS","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Anktiva","generic_name":"INBAKICEPT","company_name":"Altor Bioscience, Llc, An Indirect Wholly-Owned Su","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":40,"revenue":null,"mechanism":"Anktiva works by targeting a specific target to treat BCG-unresponsive nonmuscle invasive bladder cancer."},{"drug_id":"intravesical-solution","indication_name":"BCG-refractory CIS of the urinary bladder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Intravesical Solution","company_name":"Ankara Training and Research Hospital","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"inbakicept","indication_name":"BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Anktiva","generic_name":"INBAKICEPT","company_name":"Altor Bioscience, Llc, An Indirect Wholly-Owned Su","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":40,"revenue":null,"mechanism":"Anktiva works by targeting a specific target to treat BCG-unresponsive nonmuscle invasive bladder cancer."}],"pipeline":[],"offLabel":[],"totalMarketed":5,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05387655","title":"Long Term Effects of BCG Vaccination on Infectious and Immune Mediated Diseases","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4292,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04899765","title":"Measles and BCG Vaccines for Mother and Child","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":2400,"lead_sponsor_name":"Bandim Health Project","has_results":false},{"nct_id":"NCT04461379","title":"Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":908,"lead_sponsor_name":"Hospital Universitario Dr. Jose E. Gonzalez","has_results":false},{"nct_id":"NCT03121768","title":"A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)","phase":"","overall_status":"UNKNOWN","enrollment_count":761,"lead_sponsor_name":"Mansoura University","has_results":false},{"nct_id":"NCT03947138","title":"A Study of GC3107(BCG Vaccine) in Healthy Infants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":750,"lead_sponsor_name":"Green Cross Corporation","has_results":false},{"nct_id":"NCT06747455","title":"BCG for Therapeutic Use Phase Ⅲ Clinical Trial","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":438,"lead_sponsor_name":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","has_results":false},{"nct_id":"NCT04826718","title":"SARS-CoV-2/COVID-19 Infection Among Health Care Workers","phase":"","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Universidade de Cabo Verde","has_results":false},{"nct_id":"NCT04369794","title":"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"University of Campinas, Brazil","has_results":false},{"nct_id":"NCT05124340","title":"Safety and Tuberculin Conversion Following BCG Vaccination","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"PT Bio Farma","has_results":false},{"nct_id":"NCT05591339","title":"Diabetes Diagnosis, Management, Prevention and Education in Guinea-Bissau","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Bandim Health Project","has_results":false},{"nct_id":"NCT07322263","title":"Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":174,"lead_sponsor_name":"Michael A. O'Donnell","has_results":false},{"nct_id":"NCT06374914","title":"Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Dokuz Eylul University","has_results":false},{"nct_id":"NCT04673227","title":"Cytometric Immunodiagnostics of Latent Tuberculosis Infection (LTBI)","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Thomayer University Hospital","has_results":false},{"nct_id":"NCT03548233","title":"BCG Vaccination Scar Formation in Children Under Five Years :Factors Affecting Its Formation and Subsequent Adverse Effects .","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT04347876","title":"Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT05946369","title":"Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT06628544","title":"Trained Immunity in Fungal Infection and Its Mechanism","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":79,"lead_sponsor_name":"Zhongnan Hospital","has_results":false},{"nct_id":"NCT06441110","title":"Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":76,"lead_sponsor_name":"Fujian Medical University Union Hospital","has_results":false},{"nct_id":"NCT03984890","title":"Vitamin D3 For CGD Patients With BCGosis/Itis","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT04064554","title":"Clinical Study to Evaluate Safety and Immunogenicity of Bacillus Calmette-Guerin (BCG) Delivery Via Novel Micronjet600 Device Compared to Those Via Conventional Needle","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT03053635","title":"Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Theralase® Technologies Inc.","has_results":false},{"nct_id":"NCT03335059","title":"Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors.","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Medical Enterprises Ltd.","has_results":false},{"nct_id":"NCT03549650","title":"Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Sir Mortimer B. Davis - Jewish General Hospital","has_results":false},{"nct_id":"NCT04384614","title":"Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Direction des Soins de Santé de Base","has_results":false}],"total":24},"guidelines":[],"source":"Drug Landscape verified database"}